RSS   Newsletter   Contact   Advertise with us
Post Online Media

Immune Design appoints Sergey Yurasov as senior vice president

Immune DesignImmune Design, a clinical-stage immunotherapy company, appoints Sergey Yurasov as senior vice president of clinical development and chief medical officer.
Article continues below

READ MORE Immune Design appoints chief business officer

A board-certified, U.S. licensed hematologist/oncologist with more than 20 years of experience in immunology and oncology, Dr. Yurasov joins Immune Design from Clovis Oncology, where he most recently served as Senior Vice President.

Prior to Clovis, Dr. Yurasov served as Associate Vice-President, Global Medicine Science, at ImClone Systems, a subsidiary of Eli Lilly & Co.. He also served at Hoffman-La Roche as Clinical Director of Oncology, Pharma Research and Early Development.

Prior to his industry experience, Dr. Yurasov was Assistant Professor of Clinical Investigation at Rockefeller University, where he was the principal investigator for NIH funded translational immunology research, and Clinical Instructor in the Department of Pediatrics at Memorial Sloan-Kettering Cancer Center, where he was an attending physician.

Dr. Yurasov received his M.D. from the Russian State Medical University and his Ph.D. in medical sciences from the Research Institute for Pediatric Oncology in Moscow, Russia.

Dr. Yuraso thereafter completed his residency in general pediatrics at Albert Einstein College of Medicine/Jacobi Medical Center and his subspecialty training in pediatric hematology/oncology at Memorial Sloan-Kettering Cancer Center while serving as a research fellow at The Rockefeller University in Dr. M. Nussenzweig’s laboratory.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy